
Sign up to save your podcasts
Or


Send us a text
Surfing NASH returns to preview the second Innovations in NAFLD Care Workshop (INCBCN) to be held in Barcelona from 26-27 May, 2023. Conference founders and directors Jeff Lazarus and Jörn Schattenberg discuss what makes the event unique with Louise Campbell and Roger Green.
Roger opens with a question around the involvement of non-physicians at the Workshop. Jeff again notes the presentations by esteemed nutritionist, Shira Zelber-Sagi, and epidemiologist, Harriet Rumgay. He also highlights patient organizations that have been reached out to for participation in a roundtable. Lastly, he says feedback will be welcomed to help strengthen the future of the program and its direction. Louise then shares her thoughts on participating in last year’s panel and injecting the strength of nursing perspectives.
From here, Roger asks what the panelists anticipate in the meeting that has yet to be covered. Jeff underscores the importance of facilitating interactive sessions that prompt engaged discussion and plenty of questions. Jörn states that this is not a lecture on drugs and basic science, but an opportunity to harness developments and empower practitioners and patients alike with energized talk around how to use it.
If you enjoy the episode, have questions or interest around its contents and Fatty Liver disease, we kindly ask that you submit reviews wherever you download our discussions. Alternatively, you can write to us directly at [email protected].
Stay Safe and Surf On!
By SurfingNASH.com3.9
2424 ratings
Send us a text
Surfing NASH returns to preview the second Innovations in NAFLD Care Workshop (INCBCN) to be held in Barcelona from 26-27 May, 2023. Conference founders and directors Jeff Lazarus and Jörn Schattenberg discuss what makes the event unique with Louise Campbell and Roger Green.
Roger opens with a question around the involvement of non-physicians at the Workshop. Jeff again notes the presentations by esteemed nutritionist, Shira Zelber-Sagi, and epidemiologist, Harriet Rumgay. He also highlights patient organizations that have been reached out to for participation in a roundtable. Lastly, he says feedback will be welcomed to help strengthen the future of the program and its direction. Louise then shares her thoughts on participating in last year’s panel and injecting the strength of nursing perspectives.
From here, Roger asks what the panelists anticipate in the meeting that has yet to be covered. Jeff underscores the importance of facilitating interactive sessions that prompt engaged discussion and plenty of questions. Jörn states that this is not a lecture on drugs and basic science, but an opportunity to harness developments and empower practitioners and patients alike with energized talk around how to use it.
If you enjoy the episode, have questions or interest around its contents and Fatty Liver disease, we kindly ask that you submit reviews wherever you download our discussions. Alternatively, you can write to us directly at [email protected].
Stay Safe and Surf On!

32,317 Listeners

30,871 Listeners

9,737 Listeners

105 Listeners

21,270 Listeners

3,377 Listeners

113,207 Listeners

57,056 Listeners

9,577 Listeners

8,718 Listeners

10,275 Listeners

6,466 Listeners

0 Listeners

418 Listeners

680 Listeners